Connect with us

Health

What reports of allergic reactions to the Pfizer-BioNTech vaccine in Alaska mean – CBC.ca

Published

 on


As COVID-19 vaccinations roll out to more and more people, health authorities are keeping a close watch for any unexpected side effects.

On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer-BioNTech COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week.

In the U.S. and Canada, vaccine recipients are supposed to hang around after the injection in case signs of an allergy appear and they need immediate treatment — exactly what happened when the health worker in Juneau became flushed and short of breath 10 minutes after the shot. The second worker experienced eye puffiness, light headedness and scratchy throat.

Allergies are always a question with a new medical product, but monitoring COVID-19 vaccines for any other, unexpected side effects is a bigger challenge than usual.

It’s not just because so many people need to be vaccinated over the next year. Never before have so many vaccines made in different ways converged at the same time — and it’s possible that one shot option will come with different side effects than another.

WATCH | Allergist addresses concerns about adverse events after pandemic shots:

Dr. Zainab Abdurrahman, a clinical immunologist and allergist, said there may be sporadic severe reactions to the Pfizer-BioNTech COVID-19 vaccine, but she said we really should focus on the thousands who are being inoculated and tolerating it well. 8:54

The first vaccine beginning widespread use in the U.S. and many Western countries, made by Pfizer Inc. and Germany’s BioNTech, and a second option expected soon from competitor Moderna Inc. both are made the same way.

The U.S. Food and Drug Administration says huge studies of each have uncovered no major safety risks.

But the allergy concern “points out again the importance of real-time safety monitoring,” said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.

And authorities have multiple ways of tracking how people fare as these COVID-19 vaccines, and hopefully additional ones in coming months, get into more arms.

How will I feel after vaccination? 

Getting either the Pfizer-BioNTech shot or the Moderna version can cause some temporary discomfort, just as many vaccines do.

In addition to a sore arm, people can experience a fever and some flu-like symptoms — fatigue, aches, chills, headache. They last about a day, sometimes bad enough that recipients miss work, and are more common after the second dose and in younger people.

These reactions are a sign that the immune system is revving up. COVID-19 vaccines tend to cause more of those reactions than a flu shot, about what people experience with shingles vaccinations. But some are similar to early coronavirus symptoms, one reason hospitals are staggering when their employees get vaccinated.

What about serious risks?

The FDA found no serious side effects in the tens of thousands enrolled in studies of the two vaccines.

Still, problems so rare they don’t occur in even very large studies sometimes crop up when a vaccine is used more widely and without the stringent rules of a clinical trial.

The first allergy reports from England were in people with a history of serious allergies, and British authorities warned those with severe prior experiences to hold off vaccination as they determine what ingredient might be a problem.

U.S. health authorities are giving more nuanced advice. People always are asked about allergies before vaccinations, and instructions for the Pfizer-BioNTech shot say to avoid it if you’re severely allergic to one of its ingredients or had a severe reaction to a prior dose. Health workers can go over the ingredient list.

The U.S. Centers for Disease Control and Prevention advises people to stick around for 15 minutes after vaccination, and those with a history of other allergies for 30 minutes, so they can be treated immediately if they have a reaction.

What is Health Canada doing?

Health Canada advised earlier this week that people with allergies to any of the ingredients in the Pfizer-BioNTech COVID 19 vaccine should not receive it and should speak with their health professional about any serious allergies or other health conditions they may have before they receive this vaccine.

“Health Canada has reviewed the available evidence and has concluded that the current Product Monograph and available public health guidance are appropriate, and is not recommending any changes to the product’s use at this time,” the department said in an advisory to the general public and health professionals.

Health Canada collaborates with international regulators to share information about coronavirus vaccines as they are rolled out around the world.

“If any new safety issues are confirmed, Health Canada will take appropriate action, which could include communicating any new risks to Canadians and health-care providers or changing the recommended use of the product,” the regulator said in an advisory to the general public and health professionals.

What happened in Alaska?

The Alaska health worker, who doctors said had no history of allergies, was following that advice and got prompt care for a particularly severe reaction called anaphylaxis. She has recovered after a night of observation in the hospital — but won’t be allowed a second vaccine dose.

Alaska doctors alerted U.S. authorities, who will continue the monitoring required to tell just how common this kind of reaction really is.

That will be especially important as enough vaccine arrives for injections to be given outside of health-care settings that have lots of experience handling this type of reaction.

“Balancing any potential risks with the benefits the vaccine provides in the pandemic is an ongoing process,” CDC’s Dr. Jay Butler cautioned Wednesday.

What if other risks crop up? 

The challenge is telling whether the vaccine caused a health problem or if it’s coincidence. Health authorities have stressed that people should not jump to conclusions that there’s a connection.

The way to tell: Comparing any reports of possible side effects with data showing how often that same condition occurs routinely in the population.

The government has multiple ways to do that. Doctors are required to report any patient problems.

But the FDA is scrutinizing massive databases of insurance claims for early red flags that any health problems are occurring more often in the newly vaccinated than everyone else.

On its list to check is Bell’s palsy, a temporary facial paralysis that occurred in a handful of people in both vaccine studies. The FDA said it’s probably coincidence, but will track to be sure.

Vaccine recipients can help with the extra safety tracking. Called “v-safe,” the program run by the CDC automatically sends a daily text the first week after each vaccine dose asking how people feel, and then a weekly text for the next five weeks. Any responses that suggest concern prompt a phone call for further information.

In Canada, members of the general public who experience a potential side effect following immunization are asked to report it to their health-care professional who can also help manage any side effects.

Health Canada asks health-care professionals who have a patient that experiences a potential side effect following immunization to complete the Adverse Events Following Immunization (AEFI) form appropriate for their province or territory and send it to their local health unit.


The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Coronavirus: Dr. Bonnie outlines B.C.'s mass immunization plan | Watch News Videos Online – Globalnews.ca

Published

 on


Speaking at a press briefing on Friday, provincial health officer Dr. Bonnie Henry outlines the COVID-19 vaccine rollout schedule and when British Columbians can expect to start receiving their doses. The province says the goal is to provide 7.4 million doses and will prioritize vaccines based on age.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

COVID-19: Fraser Health declares outbreak at B.C. jail after 20 test positive – Vancouver Sun

Published

 on


Article content

Fraser Health has declared four new COVID-19 outbreaks, including at the North Fraser Pretrial Centre, where 20 people in custody have tested positive.

The health authority says it is working to identify others who may have had contact with those who tested positive at the jail in Port Coquitlam.

There have been several outbreaks in prisons and jails across Canada, including at Mission Institution in the Fraser Valley, where an inmate died in April.

Fraser Health says there are also new outbreaks at the Royal Columbian Hospital in New Westminster, the rehabilitation unit at Queen’s Park Care Centre in the same city, and the Good Samaritan Delta View Care Centre.

It says two patients tested positive for COVID-19 in a surgical unit at the hospital and the outbreak is limited to that unit.

The emergency department remains open and the health authority says other areas of the hospital are not affected by the outbreak.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

B.C. unveils plan to vaccinate millions by September – Toronto Star

Published

 on


Nearly one year after the first case of COVID-19 was identified in B.C., the province announced its plan to have everyone who wants a vaccine immunized by September.

B.C. has distributed 100,000 immunizations in the past six weeks, and the province announced its timeline for the general population on Jan. 22.

Beginning in late-February, the province will move on to Phase 2 of the vaccination rollout. From December to March 800,000 doses of vaccine are expected to arrive in B.C., from April to June 2.6 million doses, and June to September six million doses are expected in the province.

“The plan forward is one that will put 4.3 million British Columbians in a vaccinated situation by the end of September,” Premier John Horgan said.

“By the end of September everyone who wants a vaccination will have one and the community immunity that we’re all striving for will be a reality,” Horgan said.

The plan depends on a consistent supply of vaccine, which has been disrupted recently with Pfizer upscaling its production plant in Europe, Horgan said. New vaccines, not yet approved by Health Canada, will also allow amendments to the plan going forward.

The province announced plans Friday to establish vaccine distribution in clinics in 172 communities in March through local health authorities in partnership with businesses, volunteers and municipalities.

It will be the largest immunization program in the history of the province, provincial health officer Dr. Bonnie Henry said, with 8.6 million immunizations (two doses per person, 35 days apart) planned in the coming months.

People born in 1941 and earlier who were not immunized in Phase 1 are eligible to receive the vaccine in Phase 2, starting in late February and early March, as the age group eligible for vaccine moves down from there in five-year increments. Starting in mid-to-late February, health authorities will be reaching out to seniors 80 years and older and Indigenous seniors 65 and older, and Indigenous Elders, to provide information on how to pre-register for immunization appointments.

Hospital staff, community general practitioners, and medical specialists not immunized in Phase 1 will be eligible in Phase 2 as well as vulnerable populations living in congregate settings and shelters and staff in community home support and home care programs.

People aged 16 to 69 who are considered extremely vulnerable will also be eligible during this time including those with specific cancers, people receiving immunotherapy, sever respiratory conditions, rare diseases, immunosuppression therapies, adults on dialysis, people who have had their spleen removed, women who are pregnant with significant heart disease (congenital or acquired) and those with significant neuromuscular conditions requiring respiratory support.

Vaccinations to begin on general population in April

Phase 3 (April to June) will broaden the vaccine distribution into the general population. Starting with B.C. residents aged 60 to 79, who will likely get their first shot in April.

As more vaccines are approved, particularly those with less stringent transportation and temperature restrictions, other age groups may be considered during Phase 3 — specifically those between the ages of 18 and 64 who are front-line essential workers or work in specific industries.

When Phase 4 begins (July to September) vaccinations will be available for those aged 59 and under, moving down in five-year cohorts to age 18.

Loading…

Loading…Loading…Loading…Loading…Loading…

When vaccine distribution starts coming to the general population in Phases 3 and Phase 4 clinics will be held at large centres including school gymnasiums, arenas, convention and community halls and mobile clinics in self-contained vehicles will be available for some rural communities and for those who are homebound due to mobility issues, with more details coming on those operations in late February and early March.

The province’s communication plan launching in late-February will let residents know when they can expect to be vaccinated, how and where to pre-register and how to access vaccination clinics. Residents can register two to four weeks before being eligible for a vaccine.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending